Published in Biotech Business Week, January 3rd, 2005
ITP is a disorder that affects approximately 20,000 individuals in the United States and is characterized by an immune system malfunction that recognizes the body's own platelets as foreign and destroys them, potentially resulting in dangerously low platelet counts and the occurrence of spontaneous bleeding and bruising in the most severe cases.
Normal platelet range for a person without ITP is 150,000 - 400,000 platelets per microliter....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.